Learn about the types of neuroendocrine tumors. This article also discusses symptoms, causes, treatment options, and more.

Exelixis (NASDAQ:EXEL) said on Wednesday that the U.S. FDA has approved cabozantinib for patients 12 years of age and older with pancreatic neuroendocrine tumors. The approval follows promising ...

A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The ...

A study concluded that use of a multigene liquid biopsy blood biomarker for diagnosis of neuroendocrine tumors was over 94% effective at predicting tumor recurrence compared with other commonly ...

Shibuma, S., et al. (2025) Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid.

Study shows Biocept's CNSide assay detects and analyzes tumor cells in lung cancer patients, improving treatment decisions that may extend life.

Background: Previous analyses have demonstrated that a neuroendocrine tumor's site of origin correlates with tumor biology, clinical presentation, and oftentimes prognosis. There is however limited ...

Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and A The following represents disclosure information provided by ...